Cargando…
Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
OBJECTIVE: Deregulation of long noncoding RNAs (lncRNAs) is involved in the initiation and progression of cancer. LncRNA DLX6-AS1 is regarded as an oncogene in many cancer types. However, the clinical role of serum exosomal lncRNA DLX6-AS1 in cervical cancer (CC) is poorly known. This study aimed to...
Autores principales: | Ding, Xian-zhen, Zhang, Shi-qiang, Deng, Xiao-lan, Qiang, Jin-hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876577/ https://www.ncbi.nlm.nih.gov/pubmed/33550924 http://dx.doi.org/10.1177/1533033821990060 |
Ejemplares similares
-
LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020) -
Strategies of LncRNA DLX6-AS1 on Study and Therapeutics
por: Zhao, Yanyan, et al.
Publicado: (2022) -
LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020) -
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
por: Kuo, Feng-Chih, et al.
Publicado: (2022) -
Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
por: Tao, Yao, et al.
Publicado: (2020)